These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1685822)

  • 1. Identification of mutagenic site of c-H-ras oncogene damaged by N-acetoxyacetylaminofluorene(AAAF).
    Oh SH; Kim KH; Lee SE; Yeh BI
    Yonsei Med J; 1991 Sep; 32(3):207-14. PubMed ID: 1685822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational activation of H-ras oncogene transformability by alkylnitrosourea-induced DNA damage.
    Yamasaki EF; Salamon DP; Wani AA
    Mutat Res; 1992 Apr; 266(2):241-52. PubMed ID: 1373834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of H-ras codons 11 and 12 in human fibroblasts by N-ethyl-N-nitrosourea.
    Pourzand C; Cerutti P
    Carcinogenesis; 1993 Oct; 14(10):2193-6. PubMed ID: 8106179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel protein that specifically binds to DNA modified by N-acetoxy-acetylaminofluorene and cis-diamminedichloroplatinum.
    Pietrowska M; Widłak P
    Acta Biochim Pol; 2005; 52(4):867-74. PubMed ID: 15940347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene.
    Pillaire MJ; Margot A; Villani G; Sarasin A; Defais M; Gentil A
    Nucleic Acids Res; 1994 Jul; 22(13):2519-24. PubMed ID: 8041613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
    Kumar R; Dunn LL
    Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.
    Hong SJ; Lee T; Park YS; Lee KO; Chung BH; Lee SH
    Yonsei Med J; 1996 Dec; 37(6):371-9. PubMed ID: 9048488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic mutation analysis by RFLP/PCR.
    Pourzand C; Cerutti P
    Mutat Res; 1993 Jul; 288(1):113-21. PubMed ID: 7686255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons.
    Weismanová E; Kalúz S; Skorvaga M
    Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Point mutation of c-Ha-ras oncogene in oral cancers].
    Liu XF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Nov; 26(6):326-8, 388. PubMed ID: 1820236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
    Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of K-ras codon 12 mutation by polymerase chain reaction and differential dot-blot hybridization in sodium saccharin-treated human RSA cell.
    Suzuki H; Suzuki N
    Biochem Biophys Res Commun; 1993 Oct; 196(2):956-61. PubMed ID: 8240373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codons 12 and 13 of H-ras protooncogene interrupt the progression of DNA synthesis catalyzed by DNA polymerase alpha.
    Hoffmann JS; Fry M; Ji J; Williams KJ; Loeb LA
    Cancer Res; 1993 Jun; 53(12):2895-900. PubMed ID: 8504430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of H-ras oncogene activation in mouse squamous carcinoma induced by an alkylating agent.
    Hochwalt AE; Solomon JJ; Garte SJ
    Cancer Res; 1988 Feb; 48(3):556-8. PubMed ID: 2891437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.